Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. 1986

J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska

A placebo-controlled single-blind study on acute effects of captopril on hypoxic pulmonary hypertension was performed in 15 patients with severe chronic obstructive lung disease recovering from right heart failure. Ten patients received active drug (25 mg captopril orally), five patients received placebo and served as control subjects. Before drug administration, there was no difference in lung function data and pulmonary hemodynamics between patients in both groups. Captopril produced highly significant fall in systemic arterial pressure. No change in breathing frequency, minute ventilation, and pulmonary gas exchange was observed. There was no significant change in studied variables after placebo. The presented data suggest that captopril does not decrease pulmonary vascular resistance in patients with hypoxic pulmonary hypertension. A fall in pulmonary wedge pressure reflects a decrease in left ventricular afterload.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
November 1986, Japanese circulation journal,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
December 1963, Vnitrni lekarstvi,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
July 1964, Minerva cardioangiologica,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
February 1991, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
June 1956, Jornal do medico,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
January 1955, Ergebnisse der inneren Medizin und Kinderheilkunde,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
January 1993, Heart disease and stroke : a journal for primary care physicians,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
July 1949, The Journal-lancet,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
October 1972, Klinische Wochenschrift,
J Zieliński, and I Hawrylkiewicz, and D Górecka, and J Gluskowski, and M Kościńska
November 1966, Progress in cardiovascular diseases,
Copied contents to your clipboard!